France· FR:68521045
FINGOLIMOD TEVA 0,25 mg, gélule
A medicinal product containing chlorhydrate de fingolimod, registered in France by TEVA SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE FINGOLIMOD
- Manufacturer
- TEVA SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093022402130 plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 1 gélule(s)EUR 618.21
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de fingolimod in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandFingolimod Devatis 0.25 mg, KapselnDevatis AG
- FinlandFingolimod DevatisDevatis GmbH
- CzechiaGILENYANovartis Europharm Limited, Dublin
- SpainFINGOLIMOD SWANPOND INVESTMENTS 0,25 MG CAPSULAS DURAS EFGSwan Pond Investments Limited
- SwedenFingolimod Devatis 0,25 mg Kapsel, hårdDevatis GmbH
- BelgiumFingolimod Teva 0.25 mgTeva Pharma Belgium
- PolandFingolimod TevaTeva Pharmaceuticals Polska Sp. z o.o.
- NetherlandsFingolimod Devatis 0,25 mg, harde capsulesDevatis GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Areleptan, Chantico
- Belgium · Fingolimod Ab, Fingolimod Eg
- Bulgaria · Chantico, Inzolfi
- Cyprus · Fingolimod Adelco, Fingolimod Remedica
- Czechia · Areleptan, Bonaxon
- Germany · Fingod, Fingolimod 123 Acurae Pharma
- Denmark · Areleptan, Bonaxon
- Estonia · Chantico, Efigalo
- Spain · Fingolimod, Fingolimod Aurovitas
- Finland · Fingolimod, Fingolimod Avansor
- United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
- Greece · Fingolimod Adelco, Fingolimod Medochemie
- Croatia · Areleptan, Arlesias
- Hungary · Bonaxon, Chantico
- Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
- Iceland · Fingolimod, Fingolimod Accord
- Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
- Liechtenstein · Fingolimod Accord, Fingolimod Mylan
- Lithuania · Chantico, Efigalo
- Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
- Latvia · Bonaxon, Chantico
- Malta · Fingolimod Denk, Fingolimod Remedica
- Netherlands · Chantico, Fenoxa
- Norway · Areleptan, Fingolimod Accord
- Poland · Bonaxon, Chantico
- Portugal · Bluesar, Fingolimod Bluefish
- Romania · Fingolimod Dr. Reddys, Fingolimod Msn
- Sweden · Areleptan, Fingolimod Amarox
- Slovenia · Areleptan, Arlesias
- Slovakia · Areleptan, Bonaxon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1fc97fc6-2189-4770-a8e9-27f9b89ca0ce GET /v1/drugs/1fc97fc6-2189-4770-a8e9-27f9b89ca0ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68521045",
"date_amm": "2020-09-22",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE FINGOLIMOD",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de fingolimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.